This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
1gag
From Proteopedia
OCA (Talk | contribs)
(New page: 200px<br /> <applet load="1gag" size="450" color="white" frame="true" align="right" spinBox="true" caption="1gag, resolution 2.7Å" /> '''CRYSTAL STRUCTURE OF...)
Next diff →
Revision as of 14:55, 12 November 2007
|
CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH A BISUBSTRATE INHIBITOR
Contents |
Overview
Protein kinase inhibitors have applications as anticancer therapeutic, agents and biological tools in cell signaling. Based on a phosphoryl, transfer mechanism involving a dissociative transition state, a potent and, selective bisubstrate inhibitor for the insulin receptor tyrosine kinase, was synthesized by linking ATPgammaS to a peptide substrate analog via a, two-carbon spacer. The compound was a high affinity competitive inhibitor, against both nucleotide and peptide substrates and showed a slow off-rate., A crystal structure of this inhibitor bound to the tyrosine kinase domain, of the insulin receptor confirmed the key design features inspired by a, dissociative transition state, and revealed that the linker takes part in, the octahedral coordination of an active site Mg2+. These studies suggest, a general strategy for the development of selective protein kinase, inhibitors.
Disease
Known diseases associated with this structure: Diabetes mellitus, insulin-resistant, with acanthosis nigricans OMIM:[147670], Hyperinsulinemic hypoglycemia, familial, 5 OMIM:[147670], Leprechaunism OMIM:[147670], Rabson-Mendenhall syndrome OMIM:[147670]
About this Structure
1GAG is a Single protein structure of sequence from Homo sapiens with MG and 112 as ligands. Active as Transferase, with EC number and 2.7.10.2 2.7.10.1 and 2.7.10.2 Full crystallographic information is available from OCA.
Reference
Mechanism-based design of a protein kinase inhibitor., Parang K, Till JH, Ablooglu AJ, Kohanski RA, Hubbard SR, Cole PA, Nat Struct Biol. 2001 Jan;8(1):37-41. PMID:11135668
Page seeded by OCA on Mon Nov 12 17:02:18 2007
